Macular scan OCT could be used for glaucoma

Article

Macular scan OCT could be used for the diagnosis and management of glaucoma.

Macular scan OCT could be used for the diagnosis and management of glaucoma.

Dr Whitney Boling and her team, Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, Indiana, studied the OCT macula scans and automated visual field (VF) defects of 127 eyes of 127 glaucoma patients.

The superior inner and outer sectors and the inferior inner and outer sectors were recorded by macular scan OCT. Superior outer, superior inner, inferior inner, and inferior outer rows were used to determine VFs. OCT macular scan sectors and VF rows were compared using the Spearman correlation.

There were statistically significant structural relationships between all macular parameters and the related VF defects. The highest correlations were between the inferior outer macular thickness and the superior outer VF region, the inferior inner macular and the superior inner VF region, the superior inner macula and the inferior inner VF region, and the superior outer macular and the inferior outer VF region.

Macular scan OCT should be considered as a tool for the diagnosis and management of glaucoma, due to the predictable and significant structural relationship between macular thickness and VF defects.

To read the abstract please visit the Journal of Glaucoma.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.